Marjolein S Bulthuis
Overview
Explore the profile of Marjolein S Bulthuis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
36
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Gennip L, Thomas R, Bulthuis M, Hannink G, Bronkhorst E, Blijlevens N, et al.
Support Care Cancer
. 2024 Dec;
33(1):57.
PMID: 39731661
No abstract available.
2.
van Gennip L, Thomas R, Bulthuis M, Hannink G, Bronkhorst E, Blijlevens N, et al.
Support Care Cancer
. 2024 Nov;
32(12):816.
PMID: 39578296
Purpose: Oral focus screening is recommended before HCT (haematopoietic cell transplantation). Acute foci are generally treated pre-HCT. However, it is unclear whether chronic foci should be treated pre-HCT. This study...
3.
Bulthuis M, van Gennip L, Thomas R, van Leeuwen S, Bronkhorst E, Laheij A, et al.
BMC Oral Health
. 2024 Sep;
24(1):1058.
PMID: 39256697
Background: The aim of this study was to describe salivary flow rate, subjective oral dryness and dental caries 5 years post haematopoietic cell transplantation (HCT). Methods: HCT survivors of a...
4.
Bulthuis M, van Leeuwen S, Thomas R, van Gennip L, Whiteside H, Isom S, et al.
Transplant Cell Ther
. 2024 Jan;
30(4):446.e1-446.e11.
PMID: 38242439
Xerostomia, or subjective oral dryness, is a serious complaint after hematopoietic cell transplantation (HCT). Xerostomia is rated as one of the most bothersome symptoms by HCT recipients, negatively affecting quality...
5.
Bulthuis M, van Gennip L, Thomas R, Bronkhorst E, Laheij A, Raber-Durlacher J, et al.
Clin Oral Investig
. 2023 Oct;
27(12):7369-7381.
PMID: 37853264
Objectives: Haematopoietic cell transplantation (HCT) preceded by a conditioning regimen is an established treatment option for (non)malignant haematologic disorders. We aim to describe the development of hyposalivation over time in...
6.
Bulthuis M, van Gennip L, Bronkhorst E, Blijlevens N, Huysmans M, van Leeuwen S, et al.
Support Care Cancer
. 2023 Jul;
31(8):449.
PMID: 37421511
Objective: The aim of the present systematic review is to assess the prevalence and severity of and distress caused by xerostomia over time in adult hematopoietic stem cell transplantation (HSCT)...
7.
van Gennip L, Bulthuis M, Blijlevens N, Huysmans M, van Leeuwen S, Thomas R
Oral Dis
. 2022 Aug;
29(7):2578-2591.
PMID: 36004454
Objective: A systematic review was conducted to assess scientific knowledge concerning the effect of haematopoietic stem cell transplantation (HSCT) on the occurrence of caries, periodontal conditions and tooth loss, and...
8.
Bulthuis M, van Gennip L, Thomas R, Bronkhorst E, Laheij A, Raber-Durlacher J, et al.
Caries Res
. 2022 Jun;
56(3):187-196.
PMID: 35724637
Haematopoietic stem cell transplantation (HSCT) preceded by a conditioning regimen is an established treatment option for many haematological diseases. Decreased salivary flow rates after HSCT may increase caries risk. We...
9.
Bulthuis M, Jager D, Brand H
Clin Oral Investig
. 2018 Mar;
22(9):3121-3127.
PMID: 29520470
Objective: This aimed to assess the potential role of chronic stress in saliva secretion, xerostomia, and oral health in a population attending a saliva clinic. Materials And Methods: Data of...